BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9393231)

  • 1. Case finding for the fragile X syndrome and its consequences.
    Turner G; Robinson H; Wake S; Laing S; Partington M
    BMJ; 1997 Nov; 315(7117):1223-6. PubMed ID: 9393231
    [No Abstract]   [Full Text] [Related]  

  • 2. Population screening for fragile X.
    Turner G; Robinson H; Laing S; van den Berk M; Colley A; Goddard A; Sherman S; Partington M
    Lancet; 1992 May; 339(8803):1210-3. PubMed ID: 1349946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Screening for fragile X syndrome. International experiences].
    Vuust J; Larsen LA; Grønskov K; Nørgaard-Pedersen B; Brøndum-Nielsen K
    Ugeskr Laeger; 2006 Oct; 168(43):3704-9. PubMed ID: 17069733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should all pregnant women be offered carrier testing for fragile X syndrome?
    Finucane B
    Clin Obstet Gynecol; 1996 Dec; 39(4):772-82. PubMed ID: 8934029
    [No Abstract]   [Full Text] [Related]  

  • 5. Screening for the fragile X syndrome: the necessity of international guidelines for molecular genetics predictive testing in general.
    Fryns JP
    Genet Couns; 1995; 6(4):293-6. PubMed ID: 8775414
    [No Abstract]   [Full Text] [Related]  

  • 6. Population based prenatal screening for the fragile X syndrome.
    Palomaki GE
    J Med Screen; 1994 Jan; 1(1):65-72. PubMed ID: 8790488
    [No Abstract]   [Full Text] [Related]  

  • 7. [Screening for carriers of the fragile X syndrome; ethical exploration].
    de Jong A; de Wert G
    Ned Tijdschr Geneeskd; 2002 Mar; 146(13):611-5. PubMed ID: 11957380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Informed choice in fragile X syndrome and its effects on prevalence.
    Robinson H; Wake S; Wright F; Laing S; Turner G
    Am J Med Genet; 1996 Jul; 64(1):198-202. PubMed ID: 8826476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetics of Fragile X syndrome and its prevention].
    Boué J; Simon-Bouy B
    J Gynecol Obstet Biol Reprod (Paris); 1997; 26(3):273-9. PubMed ID: 9265049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for fragile X syndrome: a model for genetic disorders?
    Barnicoat A
    BMJ; 1997 Nov; 315(7117):1174-5. PubMed ID: 9393215
    [No Abstract]   [Full Text] [Related]  

  • 11. Screening for fragile X syndrome: information needs for health planners.
    Murray J; Cuckle H; Taylor G; Hewison J
    J Med Screen; 1997; 4(2):60-94. PubMed ID: 9275266
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevalence and instability of fragile X alleles: implications for offering fragile X prenatal diagnosis.
    Cronister A; Teicher J; Rohlfs EM; Donnenfeld A; Hallam S
    Obstet Gynecol; 2008 Mar; 111(3):596-601. PubMed ID: 18310361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical screening score for the fragile X (Martin-Bell) syndrome.
    Laing S; Partington M; Robinson H; Turner G
    Am J Med Genet; 1991; 38(2-3):256-9. PubMed ID: 2018069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Commentary on population screening for fragile X syndrome.
    Coffee B
    Genet Med; 2010 Jul; 12(7):411-2. PubMed ID: 20535018
    [No Abstract]   [Full Text] [Related]  

  • 15. Population screening for fragile-X syndrome.
    Bonthron D; Strain L
    Lancet; 1993 Mar; 341(8847):769-70. PubMed ID: 8095681
    [No Abstract]   [Full Text] [Related]  

  • 16. A systematic review of population screening for fragile X syndrome.
    Hill MK; Archibald AD; Cohen J; Metcalfe SA
    Genet Med; 2010 Jul; 12(7):396-410. PubMed ID: 20548240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges in prenatal screening and counselling for fragile X syndrome.
    Mak AS; Leung KY
    Hong Kong Med J; 2017 Apr; 23(2):108-9. PubMed ID: 28387201
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of fragile X pre-mutation carriers in the Chinese obstetric population using a robust FMR1 polymerase chain reaction assay: implications for screening and prenatal diagnosis.
    Cheng YK; Lin CS; Kwok YK; Chan YM; Lau TK; Leung TY; Choy KW
    Hong Kong Med J; 2017 Apr; 23(2):110-6. PubMed ID: 28253484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is it time for population-based prenatal screening for fragile-X?
    Palomaki GE; Haddow JE
    Lancet; 1993 Feb; 341(8841):373-4. PubMed ID: 8094139
    [No Abstract]   [Full Text] [Related]  

  • 20. Characteristics of fragile X relatives with different attitudes toward terminating an affected pregnancy.
    Meryash DL
    Am J Ment Retard; 1992 Mar; 96(5):528-35. PubMed ID: 1562310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.